Please provide your email address to receive an email when new articles are posted on . Dapagliflozin reduced left heart filling pressures at rest and during exercise in adults with HFpEF. The data ...
Please provide your email address to receive an email when new articles are posted on . Sublingual nitroglycerin reduced pulmonary capillary wedge pressure in patients with HF with preserved ejection ...
Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) Results build on data previously presented ...
July 30, 2002 -- Noninvasive measurements of pulse amplitude ratio correlate well with measurements of pulmonary capillary wedge pressure (PCWP), according to results of a study reported in the July ...
HELP study exceeds target enrollment with 37 patients 84% initial open-label lead-in response rate to qualify for randomization Pulmonary capillary wedge pressure (PCWP) was reduced, on average, by ...
Cardiosense Presents New Analysis of the SEISMIC-HF I Study Validating its AI Algorithm for Noninvasive PCWP Assessment at the American Heart Association's 2025 Scientific Sessions Cardiosense, a ...
pill, medicine in palm of hand Researchers’ goal was to determine empagliflozin’s impact on the central hemodynamic parameters of patients with heart failure with reduced ejection fraction.
For patients who have pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), treatment with levosimendan (Simdax; Tenax Therapeutics) can improve both pulmonary ...
An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype of HF with preserved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback